Thromboxane
From Wikipedia, the free encyclopedia
| Thromboxane | |
|---|---|
| Identifiers | |
| CAS number | [] |
| PubChem | |
| MeSH | |
| Properties | |
| Molecular formula | C20H32O5 |
| Molar mass | 352.465 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
Thromboxane is a member of the family of lipids known as eicosanoids. It is produced in platelets by thromboxane-A synthase from the endoperoxides produced by the cyclooxygenase (COX) enzyme from arachidonic acid.
Thromboxane is a vasoconstrictor and a potent hypertensive agent, and it facilitates platelet aggregation. It is in homeostatic balance in the circulatory system with prostacyclin, a related compound. The widely used drug aspirin acts by inhibiting the ability of the COX enzyme to synthesize the precursors of thromboxane within platelets.
Thromboxane is named for its role in clot formation (thrombosis).
Thromboxane A2 (TXA2), produced by activated platelets, has prothrombotic properties, stimulating activiation of new platelets as well as increasing platelet aggregation.
Platelet aggregation is achieved by mediating expression of the glycoprotein complex GP IIb/IIIa in the cell membrane of platelets. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot.
It is believed that the vasoconstriction caused by thromboxanes plays a role in Prinzmetal's angina.
The production of thromboxanes can be suppressed by acetylsalicylic acid (aspirin) which inhibits the COX enzyme both non-competitively and irriversibly. The side effect of this is that people who regularly take aspirin will suffer from excessive bleeding whenever the skin is perforated.